Sign In
Buy GERN
$1.16
-0.0100 (-0.85%)
At Close: Jun 03, 2026
Geron Announces Opening of IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis
08:30am, Friday, 11'th Dec 2020
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the opening for patient screening and enrollment of the IMpactM
Geron Announces Fifty Percent Enrollment Milestone in IMerge Phase 3 Clinical Trial in Lower Risk MDS
08:30am, Thursday, 10'th Dec 2020
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced achievement of fifty percent enrollment in the IMerge Phase 3 c
Geron Reports Ten Imetelstat Presentations at American Society of Hematology Annual Meeting
04:30pm, Monday, 07'th Dec 2020
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that four oral presentations and six poster presentations conta
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Thursday, 19'th Nov 2020
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock a
Geron Corporation (GERN) John Scarlett Presents at 2020 Stifel Virtual Healthcare Conference (Transcript)
06:05pm, Tuesday, 17'th Nov 2020
Geron Corporation (GERN) John Scarlett Presents at 2020 Stifel Virtual Healthcare Conference (Transcript)
Geron Corp (GERN) CEO John Scarlett on Q3 2020 Results - Earnings Call Transcript
09:56pm, Thursday, 05'th Nov 2020
Geron Corp (GERN) CEO John Scarlett on Q3 2020 Results - Earnings Call Transcript
Geron Announces Ten Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting
04:27pm, Wednesday, 04'th Nov 2020
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that ten abstracts containing clinical data and analyses relate
Geron (NASDAQ:GERN) Rating Increased to Buy at Zacks Investment Research
01:18am, Friday, 23'rd Oct 2020
Geron (NASDAQ:GERN) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Zacks.com reports. The brokerage presently has a
Geron Co. to Post Q3 2020 Earnings of ($0.05) Per Share, B.Riley Securit Forecasts (NASDAQ:GERN)
01:36am, Saturday, 17'th Oct 2020
Geron Co. (NASDAQ:GERN) – Investment analysts at B.Riley Securit issued their Q3 2020 EPS estimates for shares of Geron in a research note issued on Wednesday, October 14th. B.Riley Securit analyst
12 Healthcare Stocks Moving In Friday's After-Market Session
12:00am, Friday, 16'th Oct 2020
Gainers
InVivo Therapeutics Hldg (NASDAQ:NVIV) shares rose 11.11% to $1.5 during Friday's after-market session. InVivo Therapeutics Hldg's trading volume hit 1.4K shares...
12 Healthcare Stocks Moving In Monday's After-Market Session
12:00am, Monday, 05'th Oct 2020
Gainers
Assertio Holdings (NASDAQ:ASRT) shares surged 7.87% to $0.74 during Monday's after-market session. Today's trading volume for this security ended up closing at 545...
Bank of New York Mellon Corp Raises Position in Geron Co. (NASDAQ:GERN)
06:06am, Sunday, 27'th Sep 2020
Bank of New York Mellon Corp increased its holdings in Geron Co. (NASDAQ:GERN) by 14.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional i
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12:00am, Thursday, 17'th Sep 2020
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron co
Geron Corporation (GERN) CEO John Scarlett Presents at H.C. Wainwright Global Investment Conference Transcript
04:23pm, Monday, 14'th Sep 2020
Geron Corporation (NASDAQ:GERN) H.C. Wainwright Global Investment Conference Sept 14, 2020, 02:30 PM ET Company Participants John Scarlett - President & CEO Conference Call Participants Vernon Ber
Geron (NASDAQ:GERN) Shares Gap Up Following Insider Buying Activity
01:26am, Friday, 28'th Aug 2020
Geron Co. (NASDAQ:GERN) gapped up before the market opened on Wednesday following insider buying activity. The stock had previously closed at $1.76, but opened at $1.93. Geron shares last traded at $1
